Financials
- Market Capitalization 5.75 M
- Employee 12
- Founded 2011
- CEO N/A
- Website www.processapharmaceuticals.com
- Headquarter Delaware, United States
- FIGI BBG003MN5ZP8
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4878 | ENVB Enveric Biosciences, Inc. - Common Stock | 1.37 USD | 0.00% | -4.86% | +4.58% | -44.20% | 6.13 M USD | ||
| 4884 | XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 2.54 USD | -1.55% | -4.51% | -11.81% | +182.85% | 6.01 M USD | ||
| 4898 | BGMS Bio Green Med Solution, Inc. - Common Stock | 0.86 USD | -3.37% | -2.27% | -1.15% | -85.67% | 5.70 M USD | ||
| 4900 | LIMN Liminatus Pharma, Inc. - Class A Common Stock | 4.23 USD | -3.86% | -16.07% | +3745.45% | +43.39% | 5.68 M USD |
Frequently asked questions about Processa Pharmaceuticals, Inc. Common
What is the Processa Pharmaceuticals, Inc. Common stock price today?
The current price of Processa Pharmaceuticals, Inc. Common (PCSA) is 2.06. Over the past 24 hours, the stock has changed by -3.29%. Follow the PCSA chart for real-time price dynamics.
What is the stock ticker of Processa Pharmaceuticals, Inc. Common?
Processa Pharmaceuticals, Inc. Common trades under the ticker PCSA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Processa Pharmaceuticals, Inc. Common stock going up?
PCSA has changed by -2.37% over the last week, +7.85% over the last month, and -7.41% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Processa Pharmaceuticals, Inc. Common?
Processa Pharmaceuticals, Inc. Common currently has a market capitalization of 5.75 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Processa Pharmaceuticals, Inc. Common earnings last quarter?
Last quarter, Processa Pharmaceuticals, Inc. Common reported earnings of -1.19 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Processa Pharmaceuticals, Inc. Common net income for the last quarter?
Processa Pharmaceuticals, Inc. Common reported net income of -3.27 M for the last quarter. The previous quarter showed -3.38 M, which means net income changed by +3.31%.
How many employees does Processa Pharmaceuticals, Inc. Common have?
As of the latest available data, Processa Pharmaceuticals, Inc. Common has 12 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Processa Pharmaceuticals, Inc. Common stock?
You can buy Processa Pharmaceuticals, Inc. Common (PCSA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Processa Pharmaceuticals, Inc. Common stock?
Investing in Processa Pharmaceuticals, Inc. Common requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PCSA chart and related analysis on metatrader.com as part of your research.